drugset / Trial / NCT00881608
Study to Evaluate Menses Induction in Women Administered Proellex
Non-randomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine the oral dose level at which the investigative drug, Proellex, is able induce menstruation.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telapristone Acetate | Other / unclassified | 3 mg | Oral |
| Subject | Telapristone Acetate | Other / unclassified | 6 mg | Oral |
| Subject | Telapristone Acetate | Other / unclassified | 12 mg | Oral |
| Subject | Telapristone Acetate | Other / unclassified | 25 mg | Oral |